Intramuscular interferon beta-1a and evolving treatment options and outcomes measurement for MS: considerations for managed care.

Christopher J Barnes; Christina Caon; John F Foley; Mark Friedman; Joseph Menzin; Kavita V Nair; Christine Nichols; Eleanor L Olvey; Gary M Owens; Michael W Pill

doi:10.18553/jmcp.2013.19.s1.1

Intramuscular interferon beta-1a and evolving treatment options and outcomes measurement for MS: considerations for managed care.

Identifier:nobleid.org/w1/20260515/D74CFABB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D74CFABB.svg?ark=w1%2F20260515%2FD74CFABB)](https://nobleid.org/work/w1/20260515/D74CFABB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Intramuscular interferon beta-1a and evolving treatment options and outcomes measurement for MS: considerations for managed care.

Identifier:nobleid.org/w1/20260515/D74CFABB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D74CFABB.svg?ark=w1%2F20260515%2FD74CFABB)](https://nobleid.org/work/w1/20260515/D74CFABB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work